Loading viewer...
investor_presentation
Format: PDF investor_presentation
HLS Therapeutics is a North American commercially-focused pharmaceutical company with operations in neuroscience and cardiovascular therapeutic areas. The company reported 2022 revenue of $61.5M USD and adjusted EBITDA of $23.8M USD, with headquarters in Toronto and operations across North America.
investor_presentation
21 Pages
investor_presentation
22 Pages
Triumph Group
Balaxi Pharmaceuticals Investor Presentation
investor_presentationinvestor_presentation
21 Pages
Balaxi Pharmaceuticals Limited